Experimental models of growth factor-mediated angiogenesis and blood-retinal barrier breakdown

General Pharmacology: Vascular System

Volumn 35, Issue 5, 2000, Pages 233-239

  Vinores, Stanley A ^a   Seo, M S ^a,b   Okamoto, N ^a,c   Ash, J D ^d   Wawrousek, E F ^e   Xiao, W H ^a   Hudish, T ^a   Derevjanik, N L ^a   Campochiaro, P A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Chonnam National University   (South Korea)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e NATIONAL EYE INSTITUTE   (United States)

Author keywords

Angiogenesis; Blood retinal barrier; Interleukin 1 beta; Platelet derived growth factor; Retinal neovascularization; Transgenic mice; Vascular endothelial growth factor

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD RETINA BARRIER; BLOOD VESSEL; CELL ASSAY; CELL MATURATION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIA; LENS; MOUSE; NONHUMAN; PERICYTE; PHENOTYPE; PHOTORECEPTOR; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; RETINA BLOOD VESSEL; RETINOPATHY; SURFACE PROPERTY; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALS; BLOOD-RETINAL BARRIER; GROWTH SUBSTANCES; ISCHEMIA; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOTORECEPTORS, VERTEBRATE;

EID: 0034581640     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(01)00117-3     Document Type: Conference Paper

References (73)

1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
2. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
3. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
4. Lens-specific VEGF-A expression induces angioblast migration and proliferation and stimulates angiogenic remodeling
5. PDGF-BB modulated endothelial proliferation and angiogenesis in vitro via PDGF β-receptors
6. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
7. Oxygen-sensing and molecular adaptation to hypoxia
8. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of blood-retinal barrier
9. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity
10. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
11. Mechanisms of retinal and choroidal neovascularization
12. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes
13. Altered distribution of basic fibroblast growth factor in diabetic retinopathy
14. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts
15. Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation
16. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta
17. Blindness caused by diabetic retinopathy
18. Migratory and proliferative effect of platelet-derived growth factor in rabbit retinal endothelial cells: Evidence of an autocrine pathway of platelet-derived growth factor
19. A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans
20. Reduced susceptibility to IL-1 and endotoxin in transgenic mice expressing IL-1 in their lens
21. Periovulatory and interleukin-1 beta-dependent up-regulation of intraovarian vascular endothelial growth factor (VEGF) in the rat: Potential role for VEGF in the promotion of periovulatory angiogenesis and vascular permeability
22. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells
23. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
24. VEGF increases retinal vascular ICAM-1 expression in vivo
25. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy
26. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium
27. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model
28. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes
29. Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischemia and reperfusion in the rat
30. Three isoforms of platelet-derived growth factors all have the capability to induce angiogenesis in vivo
31. Transgenic mice with increased expression of vascular endothelial growth factor in the retina. A new model of intraretinal and subretinal neovascularization
32. Neuronal defects and delayed would healing in mice lacking fibroblast growth factor 2
33. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates
34. Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization
35. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
36. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases
37. PDGF-BB induced chemotaxis is impaired in aged capillary endothelial cells
38. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
39. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
40. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
41. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
42. The enhancement of cellular infiltration and vascularisation of a collagenous dermal implant in the rat by platelet-derived growth factor BB
43. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1
44. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development
45. A nuclear factor-induced by hypoxia via de-novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
46. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
47. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
48. Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor
49. Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment
50. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
51. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
52. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
53. Oxygen-induced retinopathy in the mouse
54. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimeras
55. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors
56. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
57. The role of Muller cells in the formation of the blood-retinal barrier
58. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF
59. Mitogenic and chemotactic effects of platelet-derived growth factor on human retinal glial cells
60. Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF
61. Electron microscopic localization of neuron-specific enolase in rat and mouse brain
62. Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics
63. Ultrastructural localization of blood-retinal barrier breakdown in diabetic and galactosemic rats
64. Blood-ocular barrier breakdown in eyes with ocular melanoma: A potential role for vascular endothelial growth factor
65. Double-labelling for keratin and class III β-tubulin within cultured retinal pigment epithelial cells: A comparison of chromogens to yield maximum resolution of two structural proteins within the same cell
66. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease
67. Increased vascular endothelial growth factor (VEGF) and transforming growth factor-β (TGFβ) in experimental autoimmune uveoretinitis: Upregulation of VEGF without neovascularization
68. Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice
69. Vascular endothelial growth factor (VEGF), transforming growth factor-β (TGFβ), and interleukin-6 (IL-6) in experimental herpesvirus retinopathy; association with inflammation and viral infection
70. Blood-retinal barrier breakdown in experimental coronavirus retinopathy: Association with viral antigen, inflammation, and VEGF in sensitive and resistant strains
71. Progressive inflammatory disease and neovascularization in the eyes of interleukin-1β transgenic mice
72. Hyperoxia causes decreased expression of vascular endothelial growth factor and endothelial cell apoptosis in adult retina
73. Unusual topography of bovine rhodopsin promoter-lac z fusion gene expression in transgenic mouse retinas